Literature DB >> 21292024

Scavenger receptors: Implications in atherothrombotic disorders.

Mohammad Z Ashraf1, Neha Gupta.   

Abstract

Scavenger receptors are modified lipoprotein binding receptors, expressed on the surface of a variety of cells including endothelial, macrophages and platelets. The most extensively studied class B scavenger receptors comprise of CD36 and SR-BI and have been found to bind to native and modified LDL. Interaction of modified LDL to CD36 accelerates foam cell formation, the key step in atherosclerotic plaque deposition. Recently scavenger receptors have also been implicated in thrombosis. Platelet CD36 serves as a sensor of oxidative stress and modulator of platelet reactivity under hyperlipidemic conditions thus, inducing prothrombotic signals. In contrast, targeting platelet SR-BI corresponds to reduce platelet hyperreactivity in hyperlipidemia suggesting that targeting these receptors could be a promising strategy for the treatment of atherothrombotic disorders.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292024     DOI: 10.1016/j.biocel.2011.01.019

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  14 in total

Review 1.  Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis.

Authors:  Yuan Yuan; Peng Li; Jing Ye
Journal:  Protein Cell       Date:  2012-03-23       Impact factor: 14.870

Review 2.  Standardizing scavenger receptor nomenclature.

Authors:  Mercy Prabhudas; Dawn Bowdish; Kurt Drickamer; Maria Febbraio; Joachim Herz; Lester Kobzik; Monty Krieger; John Loike; Terry K Means; Soren K Moestrup; Steven Post; Tatsuya Sawamura; Samuel Silverstein; Xiang-Yang Wang; Joseph El Khoury
Journal:  J Immunol       Date:  2014-03-01       Impact factor: 5.422

3.  Mipu1 overexpression protects macrophages from oxLDL-induced foam cell formation and cell apoptosis.

Authors:  Shun-Lin Qu; Wen-Jing Fan; Chi Zhang; Fang Guo; Dan Han; Wen-Jun Pan; Wei Li; Da-Ming Feng; Zhi-Sheng Jiang
Journal:  DNA Cell Biol       Date:  2014-12       Impact factor: 3.311

4.  A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease.

Authors:  Mercy R PrabhuDas; Cynthia L Baldwin; Paul L Bollyky; Dawn M E Bowdish; Kurt Drickamer; Maria Febbraio; Joachim Herz; Lester Kobzik; Monty Krieger; John Loike; Benita McVicker; Terry K Means; Soren K Moestrup; Steven R Post; Tatsuya Sawamura; Samuel Silverstein; Robert C Speth; Janice C Telfer; Geoffrey M Thiele; Xiang-Yang Wang; Samuel D Wright; Joseph El Khoury
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

5.  Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through Toll-like receptor-4.

Authors:  Rui Liu; Yong He; Bo Li; Jun Liu; Yingang Ren; Wei Han; Xing Wang; Lihua Zhang
Journal:  Mol Cells       Date:  2012-06-12       Impact factor: 5.034

Review 6.  Surface-modified nanotherapeutics targeting atherosclerosis.

Authors:  Wenpan Li; Karina Marie Gonzalez; Jinha Chung; Minhyeok Kim; Jianqin Lu
Journal:  Biomater Sci       Date:  2022-09-27       Impact factor: 7.590

7.  Endoplasmic reticulum stress promotes macrophage-derived foam cell formation by up-regulating cluster of differentiation 36 (CD36) expression.

Authors:  Shutong Yao; Cheng Miao; Hua Tian; Hui Sang; Nana Yang; Peng Jiao; Jiju Han; Chuanlong Zong; Shucun Qin
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

8.  The chylomicron: relationship to atherosclerosis.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  Int J Vasc Med       Date:  2011-10-05

9.  Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease.

Authors:  Kim Wilkinson; Joseph El Khoury
Journal:  Int J Alzheimers Dis       Date:  2012-05-15

Review 10.  Lipid accumulation and novel insight into vascular smooth muscle cells in atherosclerosis.

Authors:  Yu-Xiao Liu; Pei-Zhe Yuan; Jie-Hong Wu; Bo Hu
Journal:  J Mol Med (Berl)       Date:  2021-08-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.